Le Lézard
Classified in: Health
Subject: AWD

Anand S. Balachandran, MD, FACC, is Being Recognized by Continental Who's Who


HUNTSVILLE, Ala., Oct. 29, 2020 /PRNewswire/ -- Anand S. Balachandran, MD, FACC, is being recognized by Continental Who's Who as a Top Cardiologist for his excellence in the field of Medicine and acknowledgment of his outstanding work as the Owner and Cardiologist of the Heart and Vascular Clinic.              

Having accrued 15 years of experience in the field of cardiology, Dr. Anand S. Balachandran is a highly respected board-certified cardiologist. Throughout his acclaimed career, he has gained expert knowledge and extensive training in coronary artery disease, cardiac arrhythmias, hypertension, hypercholesterolemia, peripheral artery disease, congestive heart failure, and other cardiac conditions. He is particularly proficient in Invasive cardiology, using open or minimally-invasive surgery to identify or treat structural or electrical abnormalities within the patient's heart structure. In his current capacity, he demonstrates the highest level of professionalism and integrity offering comprehensive cardiology services at the Heart and Vascular Clinic in Huntsville, Alabama as the Owner and lead Cardiologist of the Heart and Vascular Clinic since 2016.

Throughout his academic career, Dr. Balachandran excelled in his courses. He graduated with an MBBS from the Academy of Medical Sciences located in Kerala, India. Then he went on to complete an Internal medicine residency, graduating as Chief Resident from Brooklyn Hospital Center. He was later invited for a Cardiology Fellowship at Weill Cornell Medical Center, and Mt. Sinai-Beth Israel medical centers. He is board-certified in both internal medicine and cardiovascular disease by the American Board of Internal Medicine.

In constant pursuit of excellence, Dr. Balachandran remains abreast of the latest cardiology advancements and technologies. He has been active in medical research, authoring several articles in scientific journals, and sharing his knowledge as an invited Fellow of the American College of Cardiology. He is registered with the American Registry of Diagnostic Vascular Sonography, and also an active member of the American Society of Echocardiography, the American Society of Nuclear Cardiology, and the Society of Vascular Ultrasonography.

Dr. Balachandran dedicates his success to his parents, Dr. MRB Nair, and his mother, Dr. Viji Nair. He also dedicates this to his mentor during residency and fellowship, Dr. S. Reddy. 

Contact: Katherine Green, 516-825-5634,  [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

at 17:49
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 17:33
The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the United States, announced the overwhelming success of its 2024 "Are You O-K+" campaign, which marked May 1 (5.1) as...



News published on and distributed by: